SANJU ADHIKARI: Open Payments
NPI 1225441066 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,826 in 122 payments from 19 companies in 2025. Trend: 2023 $3,012 · 2024 $3,072 · 2025 $2,826
Food & beverage: $2,826
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 16 | $347 |
| Vanda Pharmaceuticals Inc. | 8 | $268 |
| Janssen Pharmaceuticals, Inc | 5 | $231 |
| Otsuka America Pharmaceutical, Inc. | 10 | $228 |
| Alkermes, Inc. | 10 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $204 |
| Axsome Therapeutics, Inc. | 8 | $173 |
| ABBVIE INC. | 9 | $171 |
| Corium, LLC | 5 | $121 |
Products named: REXULTI, SPRAVATO, ARISTADA, CAPLYTA, TRINTELLIX, VRAYLAR, HETLIOZ, FANAPT.
Industry payments across NC — which companies pay providers there.
